Geneesmiddelenbeleid

This motion concerns the national pharmaceutical policy in the Netherlands. It seeks to address how medicines are managed, priced, and distributed to ensure the healthcare system remains sustainable and accessible. This procedure affects the Ministry of Health, pharmaceutical companies, and patients by potentially altering how medications are procured or regulated.